GlobeImmune Secures $15,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f9206fa2-9096-4de0-bdfa-0b17afcee0ca
Date
7/2/2014
Company Name
GlobeImmune
Mailing Address
1450 Infinite Drive Louisville, CO 80027 USA
Company Description
GlobeImmune, Inc. (NASDAQ: GBIM), is a biopharmaceutical company pioneering the discovery, development and manufacturing of potent, targeted molecular immunotherapy products called Tarmogens for the treatment of cancer and infectious diseases.
Website
http://www.globeimmune.com
Transaction Type
IPO
Transaction Amount
$15,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms